BMS358 Microbiology 2 (6)

This subject continues student's study of medical microbiology largely excluding medical bacteriology. Studies of viral, fungal and parasitic infectious diseases of major body systems are conducted with an emphasis on viral and parasitic diseases. The host-parasite relationship and anti-viral, anti-fungal and anti-parasitic chemotherapy are also studied in detail as well as multi-system infections such as vector-borne zoonoses and infections of the compromised host.

Students also study methodology and laboratory techniques for diagnosis of viral, fungal and parasitic infections including aspects of biological safety.

No offerings have been identified for this subject in 2021.

Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Subject Information

Grading System



One session


School of Biomedical Sciences

Assumed Knowledge


Subject Relationships

BMS315 BMS358 is equivalent to BMS315 without the laboratory practicals

Incompatible Subjects


Learning Outcomes

Upon successful completion of this subject, students should:
  • be able to describe the causative organisms, pathogenesis, epidemiology and clinical signs of viral, fungal and parasitic diseases affecting the major body systems;
  • be able to define the range of antiviral, antifungal and antiparasitic chemotherapeutic agents available, describe their mode of action and justify their use;
  • be able to evaluate the problems associated with the compromised host and associated viral, fungal and parasitic infections; and
  • be able to explain the importance of world-wide viral infections, vector-borne viral and parasitic infections and multi-system zoonoses.


This subject will cover the following topics:
  • HOST-PARASITE RELATIONSHIPS: including evolution of parasitism and the effects of parasites hosts and the environment;
  • VIRUSES, PARASITES AND FUNGI: their structure, replication and classification Antiviral, antifungal and antiparasitic chemotherapy including selective toxicity and design; agents; resistance; classes; laboratory aspects;
  • SYSTEMATIC INFECTIONS: upper and lower respiratory tract including agents causing acute and chronic infections;
  • SEXUALLY TRANSMITTED DISEASES: agents causing acute and chronic infections. Gastrointestinal tract infections including diarrhoeal disease, parasites and the GIT, systemic infections initiated in the GIT and hepatitis;
  • CENTRAL NERVOUS SYSTEM INFECTIONS: invasion and response to invasion; protozoan meningitis; viral meningitis and encephalitis, prions, post vaccinial and post-infectious encephalitis and diseases due to helminths;
  • ACUTE AND CHRONIC INFECTIONS: of the eye, skin, muscle, joint, bone and haemopoietic system:
  • A global perspective on measles, mumps, rubella, cytomegalovirus, Epstein-Barr, influenza, human herpes virus, HIV, papilloma virus and coronavirus infections including polio and smallpox eradication;
  • VECTOR-BORNE INFECTIONS: including arboviruses, protozoan and helminth infections;
  • MULTISYSTEM ZOONOSES: arenavirus, haemorrhagic fevers and helminth infections; and
  • INFECTIONS IN THE COMPRIMISED HOST: the compromised host, the microbes, deficiencies of innate and adaptive immunity and factors affecting.

The information contained in the CSU Handbook was accurate at the date of publication: May 2021. The University reserves the right to vary the information at any time without notice.